首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

1459644

全球癌症照護臨床營養市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Clinical Nutrition For Cancer Care Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 229 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球癌症護理臨床營養市場的市場規模將從 2023 年的 58.4 億美元達到近 99.5 億美元，2024-2032 年研究期間CAGR為 6.1%。

癌症護理的臨床營養涉及專門的營養干預措施，以在整個治療過程中為癌症患者提供支持。根據個人需求，臨床營養策略可解決與癌症相關的營養挑戰，例如體重減輕、營養不良和治療相關的副作用。這些干預措施旨在提高癌症患者的整體健康狀況，最佳化治療結果，並提高癌症治療期間和治療後的生活品質。

市場動態

在多種因素的推動下，癌症護理市場的臨床營養正在顯著成長，這凸顯了營養在支持癌症患者整個治療過程中的關鍵作用。一個主要促進因素是全球癌症盛行率不斷上升，導致接受癌症治療的人數不斷增加，而癌症治療往往會影響營養狀況。臨床營養在管理與癌症治療相關的營養挑戰方面發揮關鍵作用，包括化療和放療引起的副作用、營養不良和體重減輕。醫療保健提供者認知到量身定做的營養干預措施對於改善患者的治療結果、提高他們的生活品質並支持身體耐受癌症治療的能力的重要性。此外，對營養、免疫功能和癌症結果之間聯繫的不斷了解有助於擴大採用專門的臨床營養方案。將基於證據的營養策略整合到癌症護理方案中，例如腸內和腸外營養，進一步推動市場的成長。隨著癌症照護變得越來越個人化，注重患者的整體健康，癌症照護市場的臨床營養不斷創新，為醫療保健專業人員提供了必要的工具，以滿足接受癌症治療的個人的複雜營養需求。然而，某些因素，例如有限的認知、複雜的治療方案和經濟考慮，可能會限制癌症護理市場中臨床營養的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球癌症護理臨床營養市場的各個細分市場進行了包容性評估。癌症護理行業臨床營養的成長和趨勢為本研究提供了整體方法。

市場區隔

癌症護理臨床營養市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

口服營養
腸外營養
腸內餵食配方

按階段

成人
兒科

按銷售管道

線上
零售
機構銷售

區域分析

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲癌症護理臨床營養市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。癌症護理臨床營養市場的主要參與者包括雅培營養公司、輝瑞公司、拜耳公司、雀巢健康科學公司、葛蘭素史克公司、百特國際公司、大塚控股有限公司、美贊臣公司、有限責任公司、 Danone Nutricia, Victus, Inc. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布以及其他事態發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：癌症護理公司臨床營養的競爭格局

癌症護理臨床營養市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Abbott Nutrition

公司簡介
公司收入
產品
最近的發展

Pfizer Inc.

公司簡介
公司收入
產品
最近的發展

Bayer AG

公司簡介
公司收入
產品
最近的發展

Nestle Health Science SA

公司簡介
公司收入
產品
最近的發展

GlaxoSmithKline plc

公司簡介
公司收入
產品
最近的發展

Baxter International Inc.

公司簡介
公司收入
產品
最近的發展

Otsuka Holdings Co. Ltd.

公司簡介
公司收入
產品
最近的發展

Mead Johnson & Company LLC

公司簡介
公司收入
產品
最近的發展

Danone Nutricia

公司簡介
公司收入
產品
最近的發展

Victus Inc.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112114002

The global demand for Clinical Nutrition For Cancer Care Market is presumed to reach the market size of nearly USD 9.95 Billion by 2032 from USD 5.84 Billion in 2023 with a CAGR of 6.1% under the study period 2024 - 2032.

Clinical nutrition for cancer care involves specialized nutritional interventions to support cancer patients throughout their treatment journey. Tailored to individual needs, clinical nutrition strategies address the nutritional challenges associated with cancer, such as weight loss, malnutrition, and treatment-related side effects. These interventions aim to enhance the overall well-being of cancer patients, optimize treatment outcomes, and improve their quality of life during and after cancer therapy.

MARKET DYNAMICS

The clinical nutrition for cancer care market is witnessing significant growth driven by multiple factors that highlight the pivotal role of nutrition in supporting cancer patients throughout their treatment journey. A primary driver is the increasing prevalence of cancer globally, leading to a growing population of individuals undergoing cancer therapies that often impact nutritional status. Clinical nutrition plays a critical role in managing the nutritional challenges associated with cancer treatment, including chemotherapy and radiation therapy-induced side effects, malnutrition, and weight loss. Healthcare providers recognize the importance of tailored nutrition interventions to improve patients' outcomes, enhance their quality of life, and support the body's ability to tolerate cancer therapies. Additionally, the evolving understanding of the link between nutrition, immune function, and cancer outcomes contributes to the rising adoption of specialized clinical nutrition protocols. Integrating evidence-based nutritional strategies in cancer care protocols, such as enteral and parenteral nutrition, further propels the market's growth. As cancer care becomes increasingly personalized, focusing on holistic patient well-being, the clinical nutrition for cancer care market continues to innovate, providing healthcare professionals with essential tools to address the complex nutritional needs of individuals undergoing cancer treatment. However, certain factors, such as limited awareness, complex treatment protocols, and economic considerations, may restrict the growth of clinical nutrition in the cancer care market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical nutrition for cancer care. The growth and trends of clinical nutrition for cancer care industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical nutrition for cancer care market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feeding Formulas

By Stage

Adult
Pediatric

By Sales Channel

Online
Retail
Institutional Sales

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Nutrition For Cancer Care market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Nutrition For Cancer Care market include Abbott Nutrition, Pfizer Inc., Bayer AG, Nestle Health Science S.A., GlaxoSmithKline plc, Baxter International Inc., Otsuka Holdings Co., Ltd., Mead Johnson & Company, LLC, Danone Nutricia, Victus, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CLINICAL NUTRITION FOR CANCER CARE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Stage
- 3.7.3 Market Attractiveness Analysis By Sales Channel
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL NUTRITION FOR CANCER CARE MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Oral Nutrition Historic and Forecast Sales by Regions
5.5 Parenteral Nutrition Historic and Forecast Sales by Regions
5.6 Enteral Feeding Formulas Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL NUTRITION FOR CANCER CARE MARKET ANALYSIS BY STAGE

6.1 Overview by Stage
6.2 Historical and Forecast Data
6.3 Analysis by Stage
6.4 Adult Historic and Forecast Sales by Regions
6.5 Pediatric Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL NUTRITION FOR CANCER CARE MARKET ANALYSIS BY SALES CHANNEL

7.1 Overview by Sales Channel
7.2 Historical and Forecast Data
7.3 Analysis by Sales Channel
7.4 Online Historic and Forecast Sales by Regions
7.5 Retail Historic and Forecast Sales by Regions
7.6 Institutional Sales Historic and Forecast Sales by Regions

8 . GLOBAL CLINICAL NUTRITION FOR CANCER CARE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CLINICAL NUTRITION FOR CANCER CARE COMPANIES

9.1. Clinical Nutrition For Cancer Care Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CLINICAL NUTRITION FOR CANCER CARE INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Abbott Nutrition
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Pfizer Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Bayer AG
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Nestle Health Science S.A.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. GlaxoSmithKline plc
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Baxter International Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Otsuka Holdings Co. Ltd.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Mead Johnson & Company LLC
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Danone Nutricia
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Victus Inc.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments